+44 115 974 9000
Quotient Sciences is dedicated to accelerating the development of new drugs for patients around the world
We provide formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industry. These services are provided either individually or as an integrated service offering via our Translational Pharmaceutics® platform.
Quotient Sciences to Recapitalize With Global Private Equity Firm Permira.— Quotient Sciences (@Quotient_Sci) July 18, 2019
“The investment by the Permira Funds will support Quotient’s continued growth plans... Mark Egerton, CEO, Quotient Sciences.
Full PR: https://t.co/H6hVOb58Du#CDMO #Pharma #News #Biotech #Permira pic.twitter.com/OnoA7ojk28
Welcome @Quotient_Sci as sponsor for our July 24th SDBN Speed Networking event, they'll be sponsoring the #DrugDevelopment #networking table & handing out drink tickets, thanks! https://t.co/DkfdDiRdCf #Biotech #SanDiego #events #Jobs #Hiring pic.twitter.com/T5aVhsXt7s— SDBN (@sdbn) July 11, 2019